Mitigating catastrophic biorisks | Kevin Esvelt

Published: Jan. 8, 2021, 9:30 a.m.

In a world now painfully aware of pandemics, with ever-increasing access to autonomous biological agents, how can we help channel society’s response to COVID-19 to minimize the risk of deliberate misuse? Using the challenge of securing DNA synthesis as an example, Kevin outlines the key norms and incentives governing biotechnology, lays out potential strategies for …

Mitigating catastrophic biorisks | Kevin Esvelt Read More »